CARLA REYNOSO: Open Payments
NPI 1972123602 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 15 payments from 9 companies in 2025. Trend: 2023 $271 · 2024 $213 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $150 |
| Boston Scientific Corporation | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Wegovy, WATCHMAN Access System, Kerendia, CAPVAXIVE, JARDIANCE, Attruby, ELIQUIS, CAMZYOS.
Industry payments across VA — which companies pay providers there.
